RC
Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
$3.27 -0.91% (-$0.03)
1M -7.37%
Market Cap $357.1M
P/E Ratio -
Div. Yield -
ROE 5.76%
Bulios Fair Price
$2.84
13.1% downside
Trenutna cena
$3.27
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RCKT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
47 /100
Fair P/B 0.97x
EV/EBITDA 19.79x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 17.28%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 4.08%
ROIC 97.05%
Asset turnover 0.00x
Debt
80 /100
Low Int. coverage -0.83x
Debt/Equity 0.07x
Net debt/EBITDA -25.12x
Stability
71 /100
Stable Profitable years 0
Beta 0.50x
EPS volatility 10.52%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RCKT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gaurav D. Shah
Employees
202
Headquarters
Cranbury
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report